CD274 and neoplasm: Some studies presented changes in expressive levels of immune-checkpoint proteins such as PD-1 and PD-L1 of the lymph node microenvironment and explored its correlations with prognosis (28–30), but these studies are unable to show the changes in tumor cells themselves.